-
2022-500363-12-00
4
2022-08-24
SARS CoV-2 (COVID-19)
-
2024-512791-36-00
4
2022-08-24
Treatment of moderate-to-severe Atopic dermatitis
-
2023-504648-33-00
5
2022-07-19
Oral Corticosteroid Dependent Asthma
-
2024-514372-40-00
5
2022-04-12
Anterior ST-Elevation Myocardial Infarction
-
2023-506589-30-00
5
2022-02-09
Invasive Extraintestinal Pathogenic Escherichia coli Disease
-
2022-501243-33-00
4
2022-02-03
Diffuse Large B Cell Lymphoma (a type of non-Hodgkin’s lymphoma, in pa
-
2023-503571-19-00
5
2022-01-20
Chronic Obstructive Pulmonary Disease (COPD)
-
2022-500752-39-00
5
2021-11-25
Prevention of Respiratory syncytial virus (RSV) infection in infants a
-
2022-500881-80-00
5
2021-10-29
Chronic Heart Failure With Reduced Ejection Fraction
-
2023-506897-11-00
5
2021-10-18
Non-diabetic chronic kidney disease
-
2024-511066-36-00
5
2021-10-13
Light Chain (AL) Amyloidosis
-
2024-510744-31-00
5
2021-10-06
Giant cell arteritis (GCA)
-
2024-512880-30-00
5
2021-08-27
Neovascular Age-related Macular Degeneration (wet AMD)
-
2023-505203-23-01
5
2021-07-26
Severe asthma with an eosinophilic phenotype
-
2022-500385-99-00
5
2021-06-03
SARS-CoV II infection (Coronavirus disease)
-
2024-510979-38-00
4
2021-05-27
Relapsed or refractory Classical Hodgkins Lymphoma and relapsed or ref
-
2023-508485-15-00
5
2021-04-22
Subjects with documented STEMI, presenting with persistent ischemic ch
-
2023-507086-26-00
7
2021-03-09
Relapsed or Refractory Multiple Myeloma (RRMM)
Diffuse Large B Cell L
-
2024-515858-25-00
4
2020-09-30
Subjects with a clinical diagnosis of Alzheimer's disease who are APOE
-
2023-509737-39-00
5
2020-08-19
Primary infection prophylaxis in patients with chronic lymphocytic leu
-
2023-507222-17-00
5
2020-07-24
Acute Myeloid Leukaemia
-
2023-507221-42-00
5
2020-06-03
Acute Myeloid Leukemia in First Remission
-
2022-500785-10-00
5
2019-08-23
Metastatic Castration-Resistant Prostate Cancer
-
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok